Berman Capital Advisors’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
DCP
Berman Capital Advisors's AGL Position: Q3 2021 in Review
Berman Capital Advisors increased its Agilon Health (AGL) stake by 100% in Q3 2021, buying an estimated $854 and bringing the position to 2 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.
Berman Capital Advisors first reported a position in AGL in Q2 2021 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold AGL as of Q3 2021.
- Berman Capital Advisors held 2 shares of Agilon Health worth $1K as of Q3 2021.
- Berman Capital Advisors bought 1 Agilon Health share in Q3 2021, an estimated $854.
- Agilon Health made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1787 holding.
- Berman Capital Advisors first reported a position in Agilon Health in Q2 2021 and has held it in 2 quarters since.
- 102 funds tracked by Wall St. Rank held Agilon Health as of Q3 2021.
Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.